Olanzapine pamoate monohydrate
CAS: 221373-18-8
Ref. 3D-FO26540
| 10mg | 52.00 € | ||
| 25mg | 109.00 € | ||
| 50mg | 164.00 € | ||
| 100mg | 239.00 € | ||
| 250mg | 477.00 € |
Product Information
- 4,4'-Methylenebis[3-hydroxy-2-naphthalenecarboxylic acid compound with 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]ben zodiazepine hydrate2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine 4,4'-methylenebis[3-hydro
- Olanzapine pamoate [USAN]
- 10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, 4,4'-methlenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1), monohydrate
- 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine pamoate monohydrate
- Unii-X7S6Q4Mhcb
- Zyprexa Relprevv
Olanzapine pamoate monohydrate is a prodrug of the antipsychotic drug Olanzapine. It is used for the treatment of schizophrenia and bipolar disorder. The prodrug is converted to Olanzapine in vivo, which binds to histamine H1 receptors and blocks dopamine D2 receptors. This results in an antipsychotic effect, as well as a reduction in manic episodes associated with bipolar disorder. Olanzapine pamoate has been shown to be effective in treating schizophrenia, bipolar disorder, and major depressive disorder with psychotic features. The prodrug has also been shown to have a high oral bioavailability, good tissue distribution, and low toxicity.
Chemical properties
Technical inquiry about: 3D-FO26540 Olanzapine pamoate monohydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
